Key result
Cardiovascular disease and chronic obstructive pulmonary disease share common risk factors and pathogenetic links that aggravate each other's course, complicating diagnosis and treatment.
Why the study?
CVD and COPD share common risk factors and pathogenetic links that mutually aggravate disease course, making their comorbidity a significant healthcare challenge.
This review highlights the shared risk factors, pathophysiological mechanisms, and clinical challenges in managing patients with comorbid COPD and cardiovascular disease.
Answers are grounded in this paper and cite their sources.
Emphasizes comorbidity screening in CVD and COPD care; confirms bidirectional links but leaves optimal integrated therapy open for trials.
Comorbidity is one of the most significant problems of modern healthcare. Numerous studies have analyzed the possible pathogenetic mechanisms and relationships between a wide variety of diseases. Cardiovascular (CVD) and pulmonary diseases, in particular chronic obstructive pulmonary disease (COPD), have a number of the same risk factors and pathogenetic links, which aggravate each other's course. Moreover, CVD and COPD are among the most common diseases in the world. This review provides up-to-date information on the prevalence, risk factors and pathophysiological mechanisms underlying this unfavorable combination of diseases. Some problems of diagnosis and treatment of patients with COPD and CVD are also discussed.
No takes yet. Share an insight, caveat, or question.
Chaulin et al. (2021) conducted a review in Chronic obstructive pulmonary disease and cardiovascular disease. Cardiovascular disease and chronic obstructive pulmonary disease share common risk factors and pathogenetic links that aggravate each other's course, complicating diagnosis and treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: